Credit: Getty Images. The ORAL Shift study enrolled 694 RA patients who were inadequate responders to methotrexate alone. Pfizer announced findings from a phase3b/4 trial evaluating the efficacy and ...

Morphine sulfate 10mg, 20mg, 30mg, 50mg, 60mg, 80mg, 100mg. Morphine is a full opioid agonist and is relatively selective for the mu receptor, although it can bind to other opioid receptors at higher ...

ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today announced the launch of Carbamazepine Extended-Release Capsules, 100 mg, 200 mg and 300 mg. ANI’s Carbamazepine Extended-Release ...

Viatris, which Pfizer created in 2020, voluntarily withdrew extended-release products made at a plant in Ireland after an ...

Please provide your email address to receive an email when new articles are posted on . Brixadi is the first long-acting buprenorphine injectable that is available in weekly and monthly doses.

Please provide your email address to receive an email when new articles are posted on . An oral, ultra-long-acting, extended-release risperidone capsule provided sustained therapeutic levels of ...

We are now seeing more and more generics for “extended-release” drugs, i.e., diltiazem XT, metformin ER, and others. Can we rely on these to be pharmacokinetically equivalent to the original ...

Sinotherapeutics wants to start selling a generic version of Pfizer’s extended-release JAK inhibitor Xeljanz XR. Pfizer has other ideas, prompting it to file a lawsuit setting out its objections to ...